Companies related to Neurodegenerative Diseases

Innovating Parkinson's Disease Care

Our medical research will transform healthcare. We explore the full spectrum of disease to live life to the fullest.

We are a biotech company focused on developing precision medicines for neurological and immunological diseases.

Advancing new technologies for brain health and neurostimulation

We conduct world-class, collaborative, biological research and translate discoveries for the benefit of patients.

First-in-kind stem cell therapy to combat neurodegenerative diseases, giving back treatment perspective to millions

Creatively and diligently moving fast towards an effective treatment for people with ALS.

Shifting the treatment paradigm for neurodegenerative disease towards precision medicine and disease prevention.

Research-driven biotechnology company developing epigenetic therapies for the treatment of chronic disease

Fast-track your pipeline with preclinical excellence. in vitro & in vivo research services since 1991.

Innovating through embracing complexity

Developing transformative gene therapies for patients suffering from severe rare diseases.

Analytics and training, saving lives, improving performance & early-detecting cognitive impairment

BioArctic focuses on developing disease modifying treatments for neurodegenerative diseases.

Developing innovative medicines for the treatment of neuropsychiatric and neurodegenerative diseases

Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s.

Neurotech & photomedicine

Right treatment. Right time. Real results.

Preclinical studies in gut and gut brain for therapies of tomorrow

Clinical-stage company developing novel therapeutics for diseases of high unmet need of the liver and nervous system

Better Delivery for Better Care

Leader in Alzheimer's disease research. Discovery and development of treatment for dementia. Targeting tau.

Pinpointing Dementia Early

Therapeutic Solutions for Neurodegeneration

Leading the way in lysosomal ion channel biology to address neurodegenerative diseases and metabolic storage disorders